Celcuity Inc

NEW
NAS:CELC (USA)  
$ 15.50 -0.36 (-2.27%) 07:08 PM EST
At Loss
P/B:
3.25
Market Cap:
$ 574.34M
Enterprise V:
$ 400.74M
Volume:
130.90K
Avg Vol (2M):
248.25K
Trade In:
Volume:
130.90K
At Loss
Avg Vol (2M):
248.25K

Business Description

Description
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
Name Current Vs Industry Vs History
Cash-To-Debt 2.93
Equity-to-Asset 0.6
Debt-to-Equity 0.55
Debt-to-EBITDA -1.27
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 55.35
9-Day RSI 56.31
14-Day RSI 54.77
6-1 Month Momentum % -5.45
12-1 Month Momentum % 40

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.95
Quick Ratio 14.95
Cash Ratio 14.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -35.3
Shareholder Yield % -3.65
Name Current Vs Industry Vs History
ROE % -63.22
ROA % -42.67
ROIC % -7081.59
3-Year ROIIC % -5594.67
ROC (Joel Greenblatt) % -11591.48
ROCE % -42.42

Financials (Next Earnings Date:2024-11-13 Est.)

CELC's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CELC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Celcuity Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.73
Beta -0.28
Volatility % 65.5
14-Day RSI 54.77
14-Day ATR ($) 0.621558
20-Day SMA ($) 15.4875
12-1 Month Momentum % 40
52-Week Range ($) 9.99 - 22.188
Shares Outstanding (Mil) 37.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Celcuity Inc Filings

Filing Date Document Date Form
No Filing Data

Celcuity Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Celcuity Inc Frequently Asked Questions

What is Celcuity Inc(CELC)'s stock price today?
The current price of CELC is $15.50. The 52 week high of CELC is $22.19 and 52 week low is $9.99.
When is next earnings date of Celcuity Inc(CELC)?
The next earnings date of Celcuity Inc(CELC) is 2024-11-13 Est..
Does Celcuity Inc(CELC) pay dividends? If so, how much?
Celcuity Inc(CELC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1